Literature DB >> 8386508

Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation.

Y C Patel1, M Greenwood, G Kent, R Panetta, C B Srikant.   

Abstract

The rodent SSTR2 mRNA has been reported to be alternatively spliced to generate long (SSTR2A) and short (SSTR2B) receptor isoforms which differ in sequence at their C-terminal regulatory domains. By extending the 3' nucleotide sequence of the human gene (hSSTR2) we show highly conserved intron/exon boundaries suggesting that hSSTR2 is also capable of generating spliced variants. mRNA blots of rat tissues reveal 2 transcripts of 2.8 and 2.3 kb that are differentially expressed in brain regions and multiple peripheral organs. The 2.3 kb mRNA is preferentially expressed in pituitary tumor cells (AtT-20 mouse, GH3 rat, human prolactinoma, human somatotroph adenoma), but not in rat or human insulinoma cells. This transcript shows 4 fold induction by forskolin in AtT-20 cells suggesting cAMP dependent control of SSTR2 gene expression. The abundant expression of SSTR2 gene, the occurrence of 2 isoforms and evidence of extensive regulation at both gene and peptide levels, suggests that SSTR2 is the principal SST-14 selective subtype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386508     DOI: 10.1006/bbrc.1993.1412

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells.

Authors:  Sayed Hossein Hashemi; Jia-Yi Li; Håkan Ahlman; Annica Dahlström
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.

Authors:  E S McKeen; W Feniuk; A D Michel; E J Kidd; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  Effect of gsp oncogene on somatostatin receptor subtype 1 and 2 mRNA levels in GHRH-responsive GH3 cells.

Authors:  Eunhee Kim; Sookjin Sohn; Mina Lee; Cheolyoung Park; Jeechang Jung; Seungjoon Park
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody.

Authors:  P Dournaud; Y Z Gu; A Schonbrunn; J Mazella; G S Tannenbaum; A Beaudet
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

5.  Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

Authors:  I Shimon; J E Taylor; J Z Dong; R A Bitonte; S Kim; B Morgan; D H Coy; M D Culler; S Melmed
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 6.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 7.  Pituitary somatostatin receptor signaling.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Trends Endocrinol Metab       Date:  2010-02-09       Impact factor: 12.015

Review 8.  Molecular pharmacology of somatostatin receptors.

Authors:  D Hoyer; H Lübbert; C Bruns
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

9.  Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

Authors:  M John; W Meyerhof; D Richter; B Waser; J C Schaer; H Scherübl; J Boese-Landgraf; P Neuhaus; C Ziske; K Mölling; E O Riecken; J C Reubi; B Wiedenmann
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

10.  Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation.

Authors:  Hanna Pisarek; Tomasz Stepień; Robert Kubiak; Edyta Borkowska; Marek Pawlikowski
Journal:  Thyroid Res       Date:  2009-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.